RESERPINE IN THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS
Authors: PAUL W. CLOUGH
Journal: Annals of Internal Medicine (1955)

Editorial1 September 1955RESERPINE IN THE TREATMENT OF NEUROPSYCHIATRIC DISORDERSPAUL W. CLOUGHPAUL W. CLOUGHAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-43-3-632 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptRauwolfia serpentinain the form of crude pharmacologic preparations seems to have had an important place in the folk-lore medicine of India for many years as a reputed cure for "insanity" and many other ills. More recently better documented reports of its use have appeared in Indian medical journals, most of which are not readily accessible in this country. These are now chiefly of historical interest, although they doubtless served as a stimulus to serious scientific investigation of the preparation. This study was greatly intensified following the isolation of the principal alkaloid, reserpine, by Miller, Schlittler and Bein1in the...1 MillerSchlittlerBein JMEHJ: Reserpin, der sedative Wirkstoff aus Rauwolfia Serpentina Benth, Experentia 8: 338, 1952. CrossrefMedlineGoogle Scholar2 Bein HJ: Significance of selected central mechanisms for the analysis of the action of reserpine, Ann. New York Acad. Sc. 61: 4-16, 1955. CrossrefMedlineGoogle Scholar3 Miner RW (editor): Reserpine in the treatment of neuropsychiatric, neurological, and related clinical problems, Ann. New York Acad. Sc. 61: 1-280, 1955. (Conference report.) MedlineGoogle Scholar4 Kline NS: Use of Rauwolfia serpentina Benth in neuropsychiatric conditions, Ann. New York Acad. Sc. 59: 107, 1954. CrossrefMedlineGoogle Scholar5 KlineStanley NSAM: Use of reserpine in a neuropsychiatric hospital, Ann. New York Acad. Sc. 61: 85-91, 1955. CrossrefMedlineGoogle Scholar6 BarsaKline JANS: Treatment of two hundred disturbed psychotics with reserpine, J. A. M. A. 158: 110-113, 1955. CrossrefMedlineGoogle Scholar7 Sainz AA: The use of reserpine in ambulatory and hospitalized geriatric psychotics, Ann. New York Acad. Sc. 61: 72-77, 1955. CrossrefMedlineGoogle Scholar8 BleulerStoll MWA: Clinical use of reserpine in psychiatry: Comparison with chlorpromazine, Ann. New York Acad. Sc. 61: 167-173, 1955. CrossrefMedlineGoogle Scholar9 Hollister LE: Treatment of chronic schizophrenic reactions with reserpine, Ann. New York Acad. Sc. 61: 92-100, 1955. CrossrefMedlineGoogle Scholar10 TasherChermak DCMW: The use of reserpine in shock-reversible patients and shock-resistant patients, Ann. New York Acad. Sc. 61: 108-116, 1955. CrossrefMedlineGoogle Scholar11 HoffmanKonchegul JLL: Clinical and psychological observations on psychiatric patients treated with reserpine: A preliminary report, Ann. New York Acad. Sc. 61: 144-149, 1955. CrossrefMedlineGoogle Scholar12 NoceWilliamsRapaport RHDBW: Reserpine (serpasil) in the management of the mentally ill and mentally retarded. Preliminary report, J.A.M.A. 156: 821-824, 1954. CrossrefMedlineGoogle Scholar13 Kinross-Wright V: Chlorpromazine and reserpine in the treatment of psychoses, Ann. New York Acad. Sc. 61: 174-182, 1955. CrossrefMedlineGoogle Scholar14 HodgesLaZerta HHGD: Jaundice and agranulocytosis with fatality following chlorpromazine therapy, J.A.M.A. 158: 114-116, 1955. MedlineGoogle Scholar15 BarsaKline JANS: Combined reserpine-chlorpromazine therapy in disturbed psychotics (preliminary clinical report), Am. J. Psychiat. 111: 780, 1955. CrossrefMedlineGoogle Scholar16 Eiber HB: Combined chlorpromazine-Rauwolfia serpentina therapy in essential hypertension, J.A.M.A. 158: 730-731, 1955. CrossrefMedlineGoogle Scholar17 DrakeEbaugh FRFG: The use of reserpine in office psychiatry: Preliminary report, Ann. New York Acad. Sc. 61: 198-205, 1955. CrossrefMedlineGoogle Scholar18 Smith SK: The use of reserpine in private psychiatric practice, Ann. New York Acad. Sc. 61: 206-210, 1955. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: PAUL W. CLOUGH PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPro-cognitive effects of the GlyT1 inhibitor Bitopertin in rodentsDopamine, Psychosis, and Symptom Fluctuation: A Narrative ReviewGlutamate hypothesis in schizophreniaA Double Blind Clinical Trial of Chlorpromazine and Reserpine in Acute Mental Disturbance 1 September 1955Volume 43, Issue 3Page: 632-637KeywordsAlkaloidsReserpine ePublished: 1 December 2008 Issue Published: 1 September 1955 PDF downloadLoading ...